Day One Biopharmaceuticals Inc (DAWN)
16.18
+0.14
(+0.90%)
USD |
NASDAQ |
May 17, 16:00
16.18
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Cash from Financing (Quarterly): 0.048M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.048M |
| December 31, 2023 | 0.597M |
| September 30, 2023 | 0.115M |
| June 30, 2023 | 162.10M |
| March 31, 2023 | 1.184M |
| December 31, 2022 | 1.918M |
| September 30, 2022 | 2.053M |
| June 30, 2022 | 161.93M |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.318M |
| September 30, 2021 | -0.615M |
| June 30, 2021 | 168.53M |
| March 31, 2021 | 128.88M |
| December 31, 2020 | 29.98M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.615M
Minimum
Sep 2021
168.53M
Maximum
Jun 2021
38.65M
Average
0.597M
Median
Dec 2023
Cash from Financing (Quarterly) Benchmarks
| Revolution Medicines Inc | 0.81M |
| Zentalis Pharmaceuticals Inc | 0.007M |
| Perspective Therapeutics Inc | 166.33M |
| Electromed Inc | 0.056M |
| Xtant Medical Holdings Inc | 5.179M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -49.73M |
| Cash from Investing (Quarterly) | 89.29M |
| Free Cash Flow | -170.60M |
| Free Cash Flow Per Share (Quarterly) | -0.5737 |
| Free Cash Flow Yield | -12.65% |